American Journal of Respiratory Cell and Molecular Biology · 2003 · 147 citations · 37 references
Life SciencesImmunologyMicrobiologyEnzymologyInnate ImmunityMicrobial PathogenesisAntimicrobial PeptidesEnzyme InhibitionProteolytic EnzymesSurfactantsBacterial Protease ActivityChronic Pseudomonas Aeruginosa InfectionIn Vivo Degradation StudiesMatrix Metalloproteinase ProcessingPseudomonas Species
Both in vitro and in vivo studies provide evidence that surfactant protein (SP)-A and SP-D have an important role in the innate immune response to Pseudomonas aeruginosa. In preliminary experiments characterizing the binding of SP-A to this bacteria, we observed the appearance of apparent degradation products of SP-A, and therefore we hypothesized that P. aeruginosa produces an enzyme that degrades SP-A. Incubation of SP-A with P. aeruginosa organisms from several clinical isolates resulted in concentration- and temperature-dependent degradation of SP-A that was inhibited by a metalloproteinase inhibitor, phosphoramidon. The degradative enzyme was purified by anion exchange chromatography and identified by ion trap mass spectroscopy as Pseudomonas elastase, which was shown to directly degrade SP-A and SP-D. Incubation of P. aeruginosa or purified elastase with cell-free bronchoalveolar lavage (BAL) resulted in degradation of SP-A. Furthermore, SP-A degradation fragments were detectable in BAL from lung transplant patients with cystic fibrosis. We speculate that degradation of SP-A and SP-D is a virulence mechanism in the pathogenesis of chronic P. aeruginosa infection.
37
R. William Vandivier, Valerie A. Fadok, Peter R. Hoffmann et al. · Journal of Clinical Investigation · 2002 · 373 citations · Full text